336 related articles for article (PubMed ID: 21435179)
1. Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis.
Clocchiatti A; Florean C; Brancolini C
J Cell Mol Med; 2011 Sep; 15(9):1833-46. PubMed ID: 21435179
[TBL] [Abstract][Full Text] [Related]
2. Class IIa HDACs - new insights into their functions in physiology and pathology.
Parra M
FEBS J; 2015 May; 282(9):1736-44. PubMed ID: 25244360
[TBL] [Abstract][Full Text] [Related]
3. Class IIa HDACs repressive activities on MEF2-depedent transcription are associated with poor prognosis of ER⁺ breast tumors.
Clocchiatti A; Di Giorgio E; Ingrao S; Meyer-Almes FJ; Tripodo C; Brancolini C
FASEB J; 2013 Mar; 27(3):942-54. PubMed ID: 23159930
[TBL] [Abstract][Full Text] [Related]
4. Molecular and Functional Characterization of Histone Deacetylase 4 (HDAC4).
Li L; Yang XJ
Methods Mol Biol; 2016; 1436():31-45. PubMed ID: 27246207
[TBL] [Abstract][Full Text] [Related]
5. Specific control of pancreatic endocrine β- and δ-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9.
Lenoir O; Flosseau K; Ma FX; Blondeau B; Mai A; Bassel-Duby R; Ravassard P; Olson EN; Haumaitre C; Scharfmann R
Diabetes; 2011 Nov; 60(11):2861-71. PubMed ID: 21953612
[TBL] [Abstract][Full Text] [Related]
6. Class IIa histone deacetylases: regulating the regulators.
Martin M; Kettmann R; Dequiedt F
Oncogene; 2007 Aug; 26(37):5450-67. PubMed ID: 17694086
[TBL] [Abstract][Full Text] [Related]
7. Class IIa histone deacetylases: conducting development and differentiation.
Martin M; Kettmann R; Dequiedt F
Int J Dev Biol; 2009; 53(2-3):291-301. PubMed ID: 19412888
[TBL] [Abstract][Full Text] [Related]
8. Unscheduled HDAC4 repressive activity in human fibroblasts triggers TP53-dependent senescence and favors cell transformation.
Paluvai H; Di Giorgio E; Brancolini C
Mol Oncol; 2018 Dec; 12(12):2165-2181. PubMed ID: 30315623
[TBL] [Abstract][Full Text] [Related]
9. A class of their own: exploring the nondeacetylase roles of class IIa HDACs in cardiovascular disease.
Wright LH; Menick DR
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H199-206. PubMed ID: 27208161
[TBL] [Abstract][Full Text] [Related]
10. Identification of the ankyrin repeat proteins ANKRA and RFXANK as novel partners of class IIa histone deacetylases.
Wang AH; Grégoire S; Zika E; Xiao L; Li CS; Li H; Wright KL; Ting JP; Yang XJ
J Biol Chem; 2005 Aug; 280(32):29117-27. PubMed ID: 15964851
[TBL] [Abstract][Full Text] [Related]
11. Converse role of class I and class IIa HDACs in the progression of atrial fibrillation.
Zhang D; Hu X; Li J; Hoogstra-Berends F; Zhuang Q; Esteban MA; de Groot N; Henning RH; Brundel BJJM
J Mol Cell Cardiol; 2018 Dec; 125():39-49. PubMed ID: 30321539
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2.
Jayathilaka N; Han A; Gaffney KJ; Dey R; Jarusiewicz JA; Noridomi K; Philips MA; Lei X; He J; Ye J; Gao T; Petasis NA; Chen L
Nucleic Acids Res; 2012 Jul; 40(12):5378-88. PubMed ID: 22396528
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases.
Lahm A; Paolini C; Pallaoro M; Nardi MC; Jones P; Neddermann P; Sambucini S; Bottomley MJ; Lo Surdo P; Carfí A; Koch U; De Francesco R; Steinkühler C; Gallinari P
Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17335-40. PubMed ID: 17956988
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in class IIa histone deacetylases research.
Asfaha Y; Schrenk C; Alves Avelar LA; Hamacher A; Pflieger M; Kassack MU; Kurz T
Bioorg Med Chem; 2019 Nov; 27(22):115087. PubMed ID: 31561937
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia.
Bai G; Wei D; Zou S; Ren K; Dubner R
Mol Pain; 2010 Sep; 6():51. PubMed ID: 20822541
[TBL] [Abstract][Full Text] [Related]
16. Regulation of class IIa HDAC activities: it is not only matter of subcellular localization.
Di Giorgio E; Brancolini C
Epigenomics; 2016 Feb; 8(2):251-69. PubMed ID: 26791815
[TBL] [Abstract][Full Text] [Related]
17. The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness.
Di Giorgio E; Franforte E; Cefalù S; Rossi S; Dei Tos AP; Brenca M; Polano M; Maestro R; Paluvai H; Picco R; Brancolini C
PLoS Genet; 2017 Apr; 13(4):e1006752. PubMed ID: 28419090
[TBL] [Abstract][Full Text] [Related]
18. Class II histone deacetylases: structure, function, and regulation.
Bertos NR; Wang AH; Yang XJ
Biochem Cell Biol; 2001; 79(3):243-52. PubMed ID: 11467738
[TBL] [Abstract][Full Text] [Related]
19. Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis.
Mihaylova MM; Vasquez DS; Ravnskjaer K; Denechaud PD; Yu RT; Alvarez JG; Downes M; Evans RM; Montminy M; Shaw RJ
Cell; 2011 May; 145(4):607-21. PubMed ID: 21565617
[TBL] [Abstract][Full Text] [Related]
20. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
